Latest Biotech News

The Chan‑Zuckerberg Biohub announced it had absorbed the EvolutionaryScale team to build a large‑scale initiative combining frontier compute, experimental biology, and AI to accelerate disease...

Ginkgo Bioworks secured a DARPA/BARDA BioMaP‑Consortium project agreement worth up to $22.2 million to develop cost‑reducing and scalable approaches for domestic monoclonal antibody manufacturing,...

Researchers at MIT published Nature Biotechnology results demonstrating micrometer‑scale, light‑powered electronic devices chemically attached to circulating monocytes that home to inflamed brain...

BIOVECTRA and Revolution Biomanufacturing announced a partnership to integrate Revolution’s sequence‑optimization platforms (UTR and codon usage engineering) with BIOVECTRA’s GMP process...

Hepta Bio, founded by former Illumina, Grail and Google staffers, closed a $6.7 million seed round to commercialize transformer‑based AI that reads cell‑free DNA methylation patterns for...

Intellia and partner Regeneron reported that an elderly participant dosed with nex‑z, their in vivo CRISPR therapy for ATTR amyloidosis, was hospitalized with severe liver injury and subsequently...

The U.S. Food and Drug Administration announced a second tranche of Commissioner’s National Priority Vouchers (CNPVs), accelerating review pathways for six drugs that align with administration...

Federal Trade Commission staff wrote to Novo Nordisk and Metsera raising concerns that the structure of Novo’s acquisition offer could violate the Hart‑Scott‑Rodino Act by transferring substantial...

A Nature paper demonstrated that RFdiffusion, an AI protein‑design method, can generate de novo antibodies that bind user‑specified epitopes with atomic accuracy and whose binding poses were...

Hepta Bio, founded by former Illumina and Grail staff, closed a $6.7 million seed round to commercialize a transformer‑based AI platform that analyzes cell‑free DNA methylation for organ‑specific...

Teams at Weill Cornell Medicine and Peking University reported that human gastric organoids engineered with inducible pancreatic transcription factors (NEUROG3, PDX1, MAFA) can be transplanted...

China’s Ministry of Commerce said it will lift the export ban on Illumina instruments starting Nov. 10 while keeping the company on an 'unreliable entities' list that requires government approval...

Johnson & Johnson received FDA approval expanding the label for Caplyta (originating from Intra‑Cellular Therapies) into adjunctive treatment for major depressive disorder, a regulatory win tied...

Eli Lilly reported Phase II data showing its amylin receptor agonist eloralintide achieved dose‑dependent weight losses up to ~20% at Week 48 with an apparently favorable GI tolerability profile,...

Mark Zuckerberg and Priscilla Chan’s Biohub unveiled a large‑scale initiative to merge frontier AI with experimental biology and announced the integration of EvolutionaryScale’s team — the...

A patient in Intellia Therapeutics’ in vivo CRISPR trial for transthyretin (ATTR) amyloidosis died after hospitalization for liver injury, prompting intensified safety reviews and an FDA...

The Chan Zuckerberg Biohub announced a major expansion that folds EvolutionaryScale’s AI-for-biology team into a new, large-scale initiative pairing frontier compute with experimental biology. The...

Researchers published an atomically accurate, de novo antibody design method using RFdiffusion that produced antibodies with confirmed atomic binding poses by cryo‑electron microscopy. The Nature...

Scientists demonstrated that human gastric organoids engineered with pancreatic reprogramming factors can produce insulin-secreting cells after transplantation into mice, lowering blood glucose...

Evommune, an inflammation-focused biotech, priced a $150 million initial public offering as investors showed appetite for select clinical-stage immunology names despite a constrained IPO...